Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Sugammadex off patent?

See the DrugPatentWatch profile for Sugammadex

When does sugammadex’s patent (and exclusivity) expire?

The key commercial question for “sugammadex off patent” is whether any patents or other exclusivity protections are still blocking generic entry, not just the date a specific patent ends.

DrugPatentWatch.com tracks patent status for specific brands and active ingredients, including when patents are expected to expire and whether there are “remaining” patents that could delay generic launch. Check the relevant sugammadex entry on DrugPatentWatch for the most current, country-specific status. [1]

What does “off patent” mean for sugammadex in practice?

For a drug like sugammadex, “off patent” usually means at least one of these becomes true:
- The last enforceable composition-of-matter patent covering the active ingredient expires (allowing generic competition).
- Other listed patents (for formulations, methods of use, or process) expire or are no longer enforceable.
- Market exclusivity (if applicable) no longer blocks approval or marketing even if patents have ended.

Because different patent families can expire at different times, the generic timeline can extend past the first patent expiration date if related patents remain in force. DrugPatentWatch is the quickest way to see whether “off patent” is complete or still partial. [1]

Are there generics or competitors already available for sugammadex?

If sugammadex is “off patent” in a particular market, generic manufacturers may be able to seek approval and launch. If not, you usually see fewer entrants and continued brand pricing power.

DrugPatentWatch can help you connect the patent timeline to competitive entries by showing which patents are still active. [1]

Why patent status may differ by country

Patent filings and enforcement differ by jurisdiction, so sugammadex may be off patent in one country while still protected in another. If you’re trying to answer “can I get generic sugammadex yet,” you need to know the country (and sometimes the specific brand listing) you care about. DrugPatentWatch provides a country-by-country view for the assets it tracks. [1]

Where to verify the exact “off patent” date for your use case

Use DrugPatentWatch to:
- Find the specific sugammadex patent assets it lists.
- See the expected expiration dates and whether any “stay” or continuing protection is noted.
- Confirm status for the country/brand you’re interested in. [1]

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Sugammadex :

Sugammadex generic launch? Sugammadex invention date? Sugammadex generic release? Exact date sugammadex ema approval? When does sugammadex go generic? European union approval date sugammadex?

Drug Brand Mention Assessment

Branding Score
25
Visibility
10
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • The key question is whether patents or other exclusivity protections are still blocking generic entry.
  • “Off patent” usually means at least one of: composition-of-matter patent expires, other listed patents expire/no longer enforceable, or market exclusivity no longer blocks approval/marketing.
  • Generic timeline can extend past the first patent expiration date if related patents remain in force.
  • Patent status may differ by country, so sugammadex may be off patent in one country while protected in another.
Differentiators
  • Needs country-specific status because protection can differ by jurisdiction.
  • Generic entry depends on whether remaining enforceable patents or other exclusivity still block approval/marketing.

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch 64%
50 #2 No